Searched for
RYALTRIS
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Glenmark’s nasal spray Ryaltris gets China’s NMPA nod for allergic rhinitis; to be commercialised by Grand PharmaRyaltris is a fixed-dose combination of olopatadine, an antihistamine and mometasone furoate, a corticosteroid to treat the symptoms of all...
- Glenmark arm recalls products in US for manufacturing issuesGlenmark Pharmaceuticals is recalling 45,504 bottles of Ryaltris Nasal Spray and 11,568 tubes of Ciclopirox Gel in the US due to manufactur...
- Glenmark bets on respiratory drug, licensing deals to improve businessGlenmark had gross debt of ₹3,765 crore as of June 30, 2022. The company over the years accumulated debt to fund its innovation-led R&D and...
- Glenmark's partner Hikma launches specialty drug Ryaltris in USRyaltris is the only fixed-dose combination of olopatadine hydrochloride and mometasone furoate approved by the USFDA for the treatment of ...
- Glenmark Q4 Results: Net dips 26% to Rs 173 crConsolidated revenues of the drug firm, however, rose to Rs 3,019 crore in the quarter under review as compared to Rs 2,860 crore in the ye...
- Glenmark Pharma inks exclusive licensing agreement with Lotus InternationalGlenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.
- Glenmark gets USFDA nod for nasal spray to treat seasonal allergic rhinitisGlenmark Pharmaceuticals on Friday said its subsidiary has received approval from the US health regulator to market Ryaltris, a nasal spray...
- Glenmark gets marketing approval for Ryaltris in 13 EU, UK countriesSales of the nasal spray continue to progress well in Australia, South Africa, Ukraine and Uzbekistan, it said adding the company has also ...
- Glenmark Pharma launches nasal spray Ryaltris in IndiaGlenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost fo...
- Glenmark Pharma to launch its nasal spray Ryaltris in EUThe drug relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and wate...
- Glenmark arm gets Russian health ministry nod for nasal spray RyaltrisIn Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 1...
- Glenmark inks pact with Menarini Group to commercialise nasal spray in EuropeGlenmark Specialty, a Switzerland-based unit of the company, has entered into an exclusive licensing agreement with the Menarini Group for ...
- Dr Reddy's to acquire select brands from Glenmark in Russia, UkraineDr Reddy's Laboratories on Saturday said it has inked a pact with Glenmark Pharmaceuticals to acquire its select anti-allergy brands in Rus...
- Glenmark gets approval from Australian regulator to commercialise RyaltrisGlenmark is entitled to receive commercial milestone payments from Seqirus.
- Stock pick of the week: Why analysts are bullish on Glenmark Pharma despite recent price dipOut-licensing of its anti-allergic drug Ryaltris will help Glenmark save costs related to rectification, sales force and promotional activi...
- Glenmark Pharma says USFDA has issued CRL for RyaltrisThe CRL cites deficiencies in the Drug Master File pertaining to one of the active pharmaceutical ingredients and in manufacturing faciliti...
- Glenmark readies specialty, innovative pipeline as pricing challenges loom in the USGlenmark’s consolidated net profit saw a deep cut, dropping 78 per cent to Rs. 104.7 crore.
Load More
